Friend Bookmark
Signup Sign Up | Login Login | FAQ Help
Search Your Favorites:
  • Video
  • BlogU
  • Web
  • Image
  • Music
  • Question
  • Contact us
  • Main Menu
  • Home
  • Video
  • BlogU
  • Webpage
  • Image
  • Music
  • Question
  • Contact Us
  • How to Post Video
  • How to Post Photo
  • FAQ
  • ☰
List of Popular VideosVideo List of Popular WebsitesWeb List of Popular Images and MemesImage List of Popular MusicMusic List of New ArticlesBlogU

What obesity drugmakers see next in the market: More pills, easier access and drug combinations

Post date: 2026-01-24 01:50:24
Views: 0
CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare Conference in San Francisco.
Please click Here to read the full story.
 
Other Top and Latest Questions:
There's a new idea of alpha in the market that big money managers are pursuing
Advisors to the ultra rich say AI isn't a gamechanger for landing new clients
TikTok was thriving in the U.S., even before a joint venture saved it from a potential ban
Cramer says 'a big move is coming' for this financial, weighs a chip stock buy
Trump signed his Gaza 'Board of Peace' into being. Here's who's on it — and who isn't
Wall Street braced for a private credit meltdown. The risk of one is rising
Social Security has 'no bankruptcy or collapse in the cards,' economist says — but benefits may change
Capital One is buying startup Brex for $5.15 billion in credit card firm's latest deal
What obesity drugmakers see next in the market: More pills, easier access and drug combinations
Intel stock drops 15% as manufacturing troubles overshadow earnings beat


FAQ
Just copy & paste video embed ...
Share and bookmark ...
All interesting, funny, or ama ...
Home Home
User Profile My Profile
Post New Post

Tips
How to Post Video
How to Post Photo
Anti-Invalid Click System
How to make money from this website

There are currently 1493  visitor(s) online Now
Advertiser--> | Home | Anti-Invalid Click System |
copyright 2026 Friend Bookmark All rights reserved.